Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257)

Prostaglandins. 1983 Aug;26(2):211-21. doi: 10.1016/0090-6980(83)90090-4.

Abstract

6,9-Deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257) and its methyl ester (U-56467) are selective inhibitors of leukotriene C and D biosynthesis both in vitro and in vivo. In this study, we demonstrated that the principal site of inhibition may be arachidonate 5-lipoxygenase, the initial enzyme of leukotriene biosynthesis. U-60257 and its methyl ester block LTB4 synthesis in human peripheral neutrophils with an ID50 of 1.8 and 0.42 microM respectively. This inhibitory action of U-60257 on neutrophil 5-lipoxygenase can be reduced or reversed by a high concentration of exogenous arachidonic acid. U-60257 at 100 microM has no apparent effect on the following enzymes. 1) cyclooxygenase of sheep vesicular gland or human platelets; 2) 12-lipoxygenase of human platelets and 3) soybean 15-lipoxygenase. Thus, we conclude that U-60257 and its methyl ester are potent and selective inhibitors of arachidonate 5-lipoxygenase.

MeSH terms

  • Arachidonate Lipoxygenases
  • Calcimycin / pharmacology
  • Chromatography, High Pressure Liquid
  • Chromatography, Thin Layer
  • Epoprostenol / pharmacology*
  • Humans
  • Lipoxygenase Inhibitors*
  • Neutrophils / enzymology*
  • SRS-A / antagonists & inhibitors*

Substances

  • Lipoxygenase Inhibitors
  • SRS-A
  • Calcimycin
  • Epoprostenol
  • Arachidonate Lipoxygenases
  • piriprost